{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:27:59Z","timestamp":1781900879648,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1D1A1B07048711"],"award-info":[{"award-number":["2018R1D1A1B07048711"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1A6A1A03015876"],"award-info":[{"award-number":["2017R1A6A1A03015876"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00251-020-01188-0","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T20:03:13Z","timestamp":1605038593000},"page":"447-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Ethnic variation in risk genotypes based on single nucleotide polymorphisms (SNPs) of the interferon-inducible transmembrane 3 (IFITM3) gene, a susceptibility factor for pandemic 2009 H1N1 influenza A virus"],"prefix":"10.1007","volume":"72","author":[{"given":"Yong-Chan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-9994","authenticated-orcid":false,"given":"Byung-Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"1188_CR1","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm.4370","volume":"23","author":"EK Allen","year":"2017","unstructured":"Allen EK et al (2017) SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans. Nat Med 23:975\u2013983. https:\/\/doi.org\/10.1038\/nm.4370","journal-title":"Nat Med"},{"key":"1188_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-virology-031413-085537","volume":"1","author":"CC Bailey","year":"2014","unstructured":"Bailey CC, Zhong G, Huang IC, Farzan M (2014) IFITM-family proteins: the cell\u2019s first line of antiviral defense. Annu Rev Virol 1:261\u2013283. https:\/\/doi.org\/10.1146\/annurev-virology-031413-085537","journal-title":"Annu Rev Virol"},{"key":"1188_CR3","doi-asserted-by":"publisher","first-page":"e0210132","DOI":"10.1371\/journal.pone.0210132","volume":"14","author":"JG Bedford","year":"2019","unstructured":"Bedford JG et al (2019) Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection. PLoS ONE 14:e0210132. https:\/\/doi.org\/10.1371\/journal.pone.0210132","journal-title":"PLoS ONE"},{"key":"1188_CR4","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","volume":"139","author":"AL Brass","year":"2009","unstructured":"Brass AL et al (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus. Cell 139:1243\u20131254. https:\/\/doi.org\/10.1016\/j.cell.2009.12.017","journal-title":"Cell"},{"key":"1188_CR5","doi-asserted-by":"publisher","unstructured":"Chen T, Xiao M, Yang J, Chen YK, Bai T, Tang XJ, Shu YL (2018) Association between rs12252 and influenza susceptibility and severity: an updated meta-analysis. Epidemiol Infect:1\u20139 https:\/\/doi.org\/10.1017\/S0950268818002832","DOI":"10.1017\/S0950268818002832"},{"key":"1188_CR6","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.15252\/embr.201642771","volume":"17","author":"AA Compton","year":"2016","unstructured":"Compton AA et al (2016) Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity. EMBO Rep 17:1657\u20131671. https:\/\/doi.org\/10.15252\/embr.201642771","journal-title":"EMBO Rep"},{"key":"1188_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri3344","volume":"13","author":"MS Diamond","year":"2013","unstructured":"Diamond MS, Farzan M (2013) The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 13:46\u201357. https:\/\/doi.org\/10.1038\/nri3344","journal-title":"Nat Rev Immunol"},{"key":"1188_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10921","volume":"484","author":"AR Everitt","year":"2012","unstructured":"Everitt AR et al (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484:519\u2013523. https:\/\/doi.org\/10.1038\/nature10921","journal-title":"Nature"},{"key":"1188_CR9","doi-asserted-by":"publisher","first-page":"e1002337","DOI":"10.1371\/journal.ppat.1002337","volume":"7","author":"EM Feeley","year":"2011","unstructured":"Feeley EM et al (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7:e1002337. https:\/\/doi.org\/10.1371\/journal.ppat.1002337","journal-title":"PLoS Pathog"},{"key":"1188_CR10","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1128\/JVI.00481-13","volume":"87","author":"SP John","year":"2013","unstructured":"John SP et al (2013) The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J Virol 87:7837\u20137852. https:\/\/doi.org\/10.1128\/JVI.00481-13","journal-title":"J Virol"},{"key":"1188_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000479087","volume":"60","author":"YC Kim","year":"2017","unstructured":"Kim YC, Jeong BH (2017) no correlation of the disease severity of influenza A virus infection with the rs12252 polymorphism of the interferon-induced transmembrane protein 3 gene. Intervirology 60:69\u201374. https:\/\/doi.org\/10.1159\/000479087","journal-title":"Intervirology"},{"key":"1188_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11259-019-09762-y","volume":"43","author":"YC Kim","year":"2019","unstructured":"Kim YC, Jeong MJ, Jeong BH (2019) Genetic characteristics and polymorphisms in the chicken interferon-induced transmembrane protein (IFITM3) gene. Vet Res Commun 43:203\u2013214. https:\/\/doi.org\/10.1007\/s11259-019-09762-y","journal-title":"Vet Res Commun"},{"key":"1188_CR13","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41423-019-0322-1","volume":"17","author":"YC Kim","year":"2019","unstructured":"Kim YC, Jeong MJ, Jeong BH (2020) Strong association of regulatory single nucleotide polymorphisms (SNPs) of the IFITM3 gene with influenza H1N1 2009 pandemic virus infection. Cell Mol Immunol 17:662\u2013664. https:\/\/doi.org\/10.1038\/s41423-019-0322-1","journal-title":"Cell Mol Immunol"},{"key":"1188_CR14","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/22221751.2020.1756696","volume":"9","author":"N Lei","year":"2020","unstructured":"Lei N et al (2020) IFITM3 affects the level of antibody response after influenza vaccination. Emerg Microbes Infect 9:976\u2013987. https:\/\/doi.org\/10.1080\/22221751.2020.1756696","journal-title":"Emerg Microbes Infect"},{"key":"1188_CR15","doi-asserted-by":"publisher","unstructured":"Li C, Zheng H, Wang Y, Dong W, Liu Y, Zhang L, Zhang Y (2019) Antiviral role of IFITM proteins in classical swine fever virus infection. Viruses 11. https:\/\/doi.org\/10.3390\/v11020126","DOI":"10.3390\/v11020126"},{"key":"1188_CR16","doi-asserted-by":"publisher","first-page":"e1003124","DOI":"10.1371\/journal.ppat.1003124","volume":"9","author":"K Li","year":"2013","unstructured":"Li K et al (2013) IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 9:e1003124. https:\/\/doi.org\/10.1371\/journal.ppat.1003124","journal-title":"PLoS Pathog"},{"key":"1188_CR17","doi-asserted-by":"publisher","first-page":"e0154366","DOI":"10.1371\/journal.pone.0154366","volume":"11","author":"R Munoz-Moreno","year":"2016","unstructured":"Munoz-Moreno R et al (2016) Antiviral role of IFITM proteins in African swine fever virus infection. PLoS ONE 11:e0154366. https:\/\/doi.org\/10.1371\/journal.pone.0154366","journal-title":"PLoS ONE"},{"key":"1188_CR18","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1016\/j.jmb.2013.09.024","volume":"425","author":"JM Perreira","year":"2013","unstructured":"Perreira JM, Chin CR, Feeley EM, Brass AL (2013) IFITMs restrict the replication of multiple pathogenic viruses. J Mol Biol 425:4937\u20134955. https:\/\/doi.org\/10.1016\/j.jmb.2013.09.024","journal-title":"J Mol Biol"},{"key":"1188_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.gene.2018.06.070","volume":"674","author":"SS Prabhu","year":"2018","unstructured":"Prabhu SS, Chakraborty TT, Kumar N, Banerjee I (2018) Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: a meta-analysis. Gene 674:70\u201379. https:\/\/doi.org\/10.1016\/j.gene.2018.06.070","journal-title":"Gene"},{"key":"1188_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12977-017-0377-y","volume":"14","author":"G Shi","year":"2017","unstructured":"Shi G, Schwartz O, Compton AA (2017) More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins. Retrovirology 14:53. https:\/\/doi.org\/10.1186\/s12977-017-0377-y","journal-title":"Retrovirology"},{"key":"1188_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12864-015-1778-8","volume":"16","author":"J Smith","year":"2015","unstructured":"Smith J et al (2015) A comparative analysis of host responses to avian influenza infection in ducks and chickens highlights a role for the interferon-induced transmembrane proteins in viral resistance. BMC Genomics 16:574. https:\/\/doi.org\/10.1186\/s12864-015-1778-8","journal-title":"BMC Genomics"},{"key":"1188_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/ni.2525","volume":"14","author":"LM Wakim","year":"2013","unstructured":"Wakim LM et al (2013) Enhanced survival of lung tissue-resident memory CD8+ T cells during infection with influenza virus due to selective expression of IFITM3. Nat Immunol 14:238\u2013245. https:\/\/doi.org\/10.1038\/ni.2525","journal-title":"Nat Immunol"},{"key":"1188_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41589-018-0213-2","volume":"109","author":"J Xu","year":"2014","unstructured":"Xu J et al (2014) Swine interferon-induced transmembrane protein, sIFITM3, inhibits foot-and-mouth disease virus infection in vitro and in vivo. Antiviral Res 109:22\u201329. https:\/\/doi.org\/10.1038\/s41589-018-0213-2","journal-title":"Antiviral Res"},{"key":"1188_CR24","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1017\/S0950268815000278","volume":"143","author":"Y Xuan","year":"2015","unstructured":"Xuan Y et al (2015) IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis. Epidemiol Infect 143:2975\u20132984. https:\/\/doi.org\/10.1017\/S0950268815000278","journal-title":"Epidemiol Infect"},{"key":"1188_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/eji.201847692","volume":"49","author":"Y\u00e1nez","year":"2019","unstructured":"Y\u00e1nez et al\u00a0(2019) IFITM proteins drive type 2 T helper cell differentiation and exacerbate allergic airway inflammation. European Journal of Immunology 49:66-78. https:\/\/doi.org\/10.1002\/eji.201847692","journal-title":"European Journal of Immunology"},{"key":"1188_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/imm.13163","volume":"159","author":"DC Y\u00e1nez","year":"2019","unstructured":"Y\u00e1nez DC, Ross S, Crompton T (2020) The IFITM protein family in adaptive immunity. Immunology 159:365\u2013372. https:\/\/doi.org\/10.1111\/imm.13163","journal-title":"Immunology"},{"key":"1188_CR27","doi-asserted-by":"publisher","first-page":"e0124985","DOI":"10.1371\/journal.pone.0124985","volume":"10","author":"X Yang","year":"2015","unstructured":"Yang X et al (2015) Interferon-inducible transmembrane protein 3 genetic variant rs12252 and influenza susceptibility and severity: a meta-analysis. PLoS ONE 10:e0124985. https:\/\/doi.org\/10.1371\/journal.pone.0124985","journal-title":"PLoS ONE"},{"key":"1188_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s40588-018-0103-0","volume":"5","author":"A Zani","year":"2018","unstructured":"Zani A, Yount JS (2018) Antiviral protection by IFITM3 in vivo. Curr Clin Microbiol Rep 5:229\u2013237. https:\/\/doi.org\/10.1007\/s40588-018-0103-0","journal-title":"Curr Clin Microbiol Rep"},{"key":"1188_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/infdis\/jiaa224","volume":"222","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020) Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19. J Infect Dis 222:34\u201337. https:\/\/doi.org\/10.1093\/infdis\/jiaa224","journal-title":"J Infect Dis"},{"key":"1188_CR30","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/ncomms2433","volume":"4","author":"YH Zhang","year":"2013","unstructured":"Zhang YH et al (2013) Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 4:1418. https:\/\/doi.org\/10.1038\/ncomms2433","journal-title":"Nat Commun"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-020-01188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00251-020-01188-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-020-01188-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T12:00:27Z","timestamp":1607515227000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00251-020-01188-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":30,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1188"],"URL":"https:\/\/doi.org\/10.1007\/s00251-020-01188-0","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"assertion":[{"value":"19 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}